These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10201335)

  • 1. Recommendations for the treatment of lipid disorders in patients on peritoneal dialysis. ISPD guidelines/recommendations. International Society for Peritoneal Dialysis.
    Fried L; Hutchison A; Stegmayr B; Prichard S; Bargman JM
    Perit Dial Int; 1999; 19(1):7-16. PubMed ID: 10201335
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins and the kidney.
    Wheeler DC
    Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):579-84. PubMed ID: 9818207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severely frail elderly patients do not need lipid-lowering drugs.
    Mallery LH; Moorhouse P; McLean Veysey P; Allen M; Fleming I
    Cleve Clin J Med; 2017 Feb; 84(2):131-142. PubMed ID: 28198686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction.
    Vogt L; Laverman GD; Dullaart RP; Navis G
    Nephrol Dial Transplant; 2004 Jan; 19(1):5-8. PubMed ID: 14671028
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dyslipidemia in renal failure].
    Fujioka T; Ueno T; Matsumoto T; Watanabe H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():118-23. PubMed ID: 15250280
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.
    Rabar S; Harker M; O'Flynn N; Wierzbicki AS;
    BMJ; 2014 Jul; 349():g4356. PubMed ID: 25035388
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
    Margaritis M; Antoniades C
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):5-8. PubMed ID: 22149521
    [No Abstract]   [Full Text] [Related]  

  • 8. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
    Duntas L; Kolovou G
    Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
    [No Abstract]   [Full Text] [Related]  

  • 9. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Rodrigues CJ
    Sao Paulo Med J; 2015; 133(6):541-2. PubMed ID: 26760127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCSK9 inhibitors- A new age in lipid management?
    Grant PJ
    Diab Vasc Dis Res; 2017 May; 14(3):171. PubMed ID: 28467196
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins for chronic kidney disease not requiring dialysis.
    Webster A; Palmer S; Ruospo M; Strippoli GF
    Nephrology (Carlton); 2015 Apr; 20(4):300-1. PubMed ID: 25810228
    [No Abstract]   [Full Text] [Related]  

  • 12. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus.
    Ichimaru N; Takahara S; Kokado Y; Wang JD; Hatori M; Kameoka H; Inoue T; Okuyama A
    Atherosclerosis; 2001 Oct; 158(2):417-23. PubMed ID: 11583721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatments for dyslipidemia associated with kidney disease].
    Hirano T; Yoshino G
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():748-52. PubMed ID: 11347167
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid-lowering therapy in high cardiovascular risk patients during COVID-19 pandemic: keep focused on the target.
    Cesaro A; Riccio C; Calabrò P
    Monaldi Arch Chest Dis; 2021 May; 91(2):. PubMed ID: 33942600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.
    Jialal I; Smith G
    Metab Syndr Relat Disord; 2012 Jun; 10(3):159-60. PubMed ID: 22568574
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of atorvastatin on dyslipidaemia in uraemic patients on peritoneal dialysis.
    Hufnagel G; Michel C; Vrtovsnik F; Queffeulou G; Kossari N; Mignon F
    Nephrol Dial Transplant; 2000 May; 15(5):684-8. PubMed ID: 10809811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering drug therapies: the evidence.
    Packard C
    Proc Nutr Soc; 2000 Aug; 59(3):423-4. PubMed ID: 10997662
    [No Abstract]   [Full Text] [Related]  

  • 19. Statins: have we found the Holy Grail?
    Jeger R; Dieterle T
    Swiss Med Wkly; 2012; 142():w13515. PubMed ID: 22315166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update: clinical lipidology].
    Parhofer KG
    MMW Fortschr Med; 2013 Jul; 155(13):49-52; quiz 53-4. PubMed ID: 23964509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.